
Life
Pancreatic cancer pill plus chemo stopped tumor growth in 90% in early study. Who can get it now
In 61 people with untreated metastatic pancreatic cancer, daraxonrasib plus chemotherapy shrank tumors in 60.7%. The FDA approved the pill in August, but only for patients already treated.
November 20, 2026 · 4 min read


